Goodwin's Jumpstart Bio breakfast series gathers leaders in the Boston biotech and pharmaceutical community to discuss the intersection of science, business, and the law. This series equips drug development and commercialization professionals to anticipate, prepare for, and respond to issues on the horizon for the industry.
Join Goodwin and the J.P. Morgan Life Sciences Commercial Banking Unit for a discussion of pressing issues facing life sciences companies looking to expand their global footprint:
- Tales from the Trenches: Traps for the unwary when planning clinical trials abroad.
- How can drug and device companies anticipate (and avoid) violations of the Foreign Corrupt Practices Act?
- Money Talk: Ensure financing smooths, rather than complicates, your global footprint.